[Paclitaxel induced apoptotic genes and pathways alterations: a review]

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Context:

• Paclitaxel (Taxol) demonstrates significant clinical efficacy across various malignant tumors.
• Understanding the precise anti-cancer mechanisms of paclitaxel is crucial for optimizing its therapeutic application.
• The market potential for effective cancer therapeutics like paclitaxel is substantial.

Purpose:

• To review the latest developments in signaling pathways involved in paclitaxel-induced apoptosis.
• To elucidate the roles of specific genes and proteins in the apoptosis process triggered by paclitaxel.
• To provide insights into the paclitaxel-producing gene in microbial fermentation.

Summary:

• Paclitaxel induces cancer cell apoptosis by arresting the cell cycle.
• Key molecular players, including cyclins and telomerase, are implicated in paclitaxel-mediated apoptosis.
• The review covers signaling pathways and genetic factors influencing paclitaxel's anti-cancer effects.

Impact:

• This review consolidates current knowledge on paclitaxel's apoptotic mechanisms.
• It highlights the importance of understanding molecular pathways for developing novel cancer therapies.
• Insights into microbial production of paclitaxel may inform future drug manufacturing processes.